Across the United States, several emerging policies are putting both medical innovation and patient access to lifesaving drugs at risk. Although these measures are often promoted as efforts to reduce healthcare costs and assert greater national control, they could end up limiting access to new treatments and slowing scienitific progress. Patients have strong reasons to […]